Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-25

Clinical Trial Update: Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the interaction between clozapine and fluvoxamine in treatment-refractory schizophrenia. The study highlights potential dosing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozaril) (Clozapine)
  • Fluvoxamine (Luvox) (Fluvoxamine)

Snippet

Sponsor: Taipei Medical University Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED